These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10809991)

  • 1. Multidrug resistance in haematological malignancies.
    Sonneveld P
    J Intern Med; 2000 May; 247(5):521-34. PubMed ID: 10809991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy resistance in acute myeloid leukaemia.
    Sonneveld P; List AF
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):211-33. PubMed ID: 11355932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug reverting activity toward leukemia cells in a group of new verapamil analogues with low cardiovascular activity.
    Biscardi M; Teodori E; Caporale R; Budriesi R; Balestri F; Scappini B; Gavazzi S; Grossi A
    Leuk Res; 2006 Jan; 30(1):1-8. PubMed ID: 16061283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of multidrug resistance (MDR) in hematological malignancies.
    Covelli A
    Ann Oncol; 1999; 10 Suppl 6():53-9. PubMed ID: 10676553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance in multiple myeloma.
    Sonneveld P; Lokhorst HM; Vossebeld P
    Semin Hematol; 1997 Oct; 34(4 Suppl 5):34-9. PubMed ID: 9408959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance in multiple myeloma.
    Sonneveld P
    Pathol Biol (Paris); 1999 Feb; 47(2):182-7. PubMed ID: 10192886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
    Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance in pediatric malignancies.
    Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance of acute leukemia and a strategy to overcome it.
    Motoji T; Motomura S; Wang YH
    Int J Hematol; 2000 Dec; 72(4):418-24. PubMed ID: 11197207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical significance of MDR-1 gene expression in the hemopoietic cells of patients with acute leukemias in different phases of the disease].
    Bykova TV; Sominskaia AA; Zaritskiĭ AIu; Stiuf IIu; Medvedeva BV; Anikina NA; Afanas'ev BV
    Ter Arkh; 1998; 70(7):11-4. PubMed ID: 9742628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y; Qian F; Wei D; Liu J
    J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of multidrug resistance (MDR) molecule in acute leukemia and lymphoma.
    Pituch-Noworolska A; Gawlicka M; Balwierz W
    Pol J Pathol; 1995; 46(2):77-82. PubMed ID: 7640950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy.
    Chauhan PS; Bhushan B; Singh LC; Mishra AK; Saluja S; Mittal V; Gupta DK; Kapur S
    Exp Mol Pathol; 2012 Feb; 92(1):44-9. PubMed ID: 22037714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
    Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
    Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoresistance and multiple myeloma: from biological to clinical aspects.
    Rossi JF
    Stem Cells; 1995 Aug; 13 Suppl 2():64-71. PubMed ID: 8520514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the neural cell adhesion molecule CD56 is not associated with P-glycoprotein overexpression in core-binding factor acute myeloid leukemia.
    Suvannasankha A; Minderman H; O'Loughlin KL; Sait SN; Stewart CC; Greco WR; Baer MR
    Leuk Res; 2004 May; 28(5):449-55. PubMed ID: 15068897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance: clinical relevance in acute leukemia.
    List AF
    Oncology (Williston Park); 1993 Oct; 7(10):23-8, 32; discussion 32, 35-8. PubMed ID: 7902728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.